| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDI1 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | VPS53 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | THEG | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | KRTAP10-12 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | TREX2 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | WDR17 | CTRPv2 | pan-cancer | AAC | 0.48 | 0.0004 |
| mRNA | CCDC188 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | POTED | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | DAND5 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | SCN11A | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
